## REVIEWER A — Domain Expert

The project is a technically rigorous, well-scoped instrumentation development effort. The PI and team bring strong relevant experience (automated microscopy, optomechanics, and laser safety). The preliminary data are extensive and appropriately controlled: 1000-cycle AI-agent validation, 300-chloroplast phototoxicity tests with positive/negative controls, and offline fallback demonstrated over 72 hours. The success metrics are quantitative and well-defined. The innovation is honest—the AI-agent layer offers modest speed advantages online but genuine resilience through offline fallback. The approach is sound: a practical open-source alternative to closed, expensive commercial systems with a clear path to Experiment A. The budget is reasonable (~$30k) and detailed. Risks are clearly identified and mitigated, particularly laser safety (LSO on site, ANSI compliance, interlock design). The main weakness is the acknowledged biological surrogate gap (Elodea ≠ mammalian centrioles), but that is not fatal for a tools-development grant. The document is exceptionally clear and transparent about limitations.

- Impact: 4
- Approach: 5
- Innovation: 4
- Preliminary Data: 5
- PI & Team: 5
- Feasibility: 5
- Experimental Design: 5
- Budget: 5
- Clarity: 5
- Ethics: 5
- Overall: 4

**Score Sum: 52/55**

## REVIEWER B — Fluff/Impact Auditor

This proposal is refreshingly honest about its scope. It does not overclaim biological impact, translational relevance, or paradigm-shifting innovation. The stated primary output—a validated open-source AI-controlled microscopy system—is genuine and achievable. The comparison table against commercial systems (µManager, Andor IQ, Zeiss Zen) is quantitative and fair, showing only a 0.33 s latency improvement online, but a stronger reliability advantage offline. The budget is lean and well-justified (~$30k). The impact on the field is moderate but real: it lowers the barrier to entry for AI-driven automated microscopy. However, the impact is incremental rather than transformative, and the biological testbed (Elodea chloroplasts) is a limited model. The proposal would benefit from a clearer articulation of who will use this system and how it will be disseminated. Overall, a solid but not high-impact project.

- Impact: 3
- Approach: 4
- Innovation: 3
- Preliminary Data: 4
- PI & Team: 3
- Feasibility: 4
- Experimental Design: 4
- Budget: 4
- Clarity: 5
- Ethics: 4
- Overall: 3

**Score Sum: 41/55**

## REVIEWER C — Red Team

While the proposal is well-structured and thorough, several critical issues remain. First, the biological surrogate gap is not just a "risk"—it fundamentally limits the validation. Elodea chloroplast phototoxicity results do not predict mammalian cell response, and the 3% phototoxicity rate under 2.3 µJ is questionable without longer-term viability checks (>1 h). Second, the AI-agent "innovation" is largely a wrapper around predetermined tool calls; the claim of "scientific reasoning" is aspirational given the validation only on a single, simple testbed. Third, offline fallback relies on a local ONNX model (EfficientNet-Lite0) trained on 10,000 synthetic images—no real-world biological images were used. The 72 h validation is on a calibration target, not on living cells with varying morphology. Fourth, the team lacks a dedicated deep-learning expert; Jane Zhao is a Ph.D. candidate with cell-tracking experience, not a computer vision specialist. Fifth, budget underestimates ongoing API costs for Claude/DeepSeek (2-year $3k is optimistic given token usage). Finally, the transition to Experiment A (iPSC-organoids) is vague; no details on how the rig will be adapted for 3D samples.

- Impact: 3
- Approach: 3
- Innovation: 3
- Preliminary Data: 3
- PI & Team: 3
- Feasibility: 3
- Experimental Design: 3
- Budget: 3
- Clarity: 4
- Ethics: 3
- Overall: 2

**Score Sum: 33/55**

## Combined Verdict

**Combined Score: MIN = 33/55**

**Recommendation: Major Revisions**

**Top 3 Actions:**

1. **Address the biological surrogate gap more concretely** — Either explicitly limit validation claims to Elodea (removing implications for mammalian work) or include a small pilot on a mammalian cell line (e.g., HeLa or fibroblast) to demonstrate the system's applicability beyond chloroplasts. Provide evidence that UV pulse energy and wavelength are safe for mammalian cells under the proposed conditions.

2. **Strengthen the AI-agent validation** — Include real microscopy images with varying biological textures (not just synthetic calibration targets) in the offline model training and testing. Demonstrate the agent's ability to handle unexpected artefacts (e.g., dust, debris, cell debris, overlapping nuclei) rather than only "partial overlap of targets". Add a dedicated computer vision or ML specialist to the team, or provide evidence that Jane Zhao's expertise is sufficient.

3. **Improve feasibility of long-term autonomous operation** — Provide more detail on the watchdog, error-recovery, and data-logging architecture for a 6-month unattended run. Include a realistic estimate of API token consumption and cost over 2 years (current $3k seems low). Clarify how the system will handle circadian or temperature-driven changes in Elodea motility over days, and verify that the offline model can adapt to slow drifts in imaging conditions.